MannKind Corporation | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (316)

Latest Posts

About This Stock More About This Stock
Cleveland-Cliffs: A Steel Producer To Target In This Resilient Market
Article By: MoneyShow.com
Sunday, April 16, 2023 1:20 PM EDT
One of the nice things about “boring” markets is that they do not require a lot of “rethinking of things,” and given just how resilient this market has been in the face of all that has been thrown at it, Cleveland-Cliffs Inc. remains attractive.
In this article: CLF Also: EA, FSLR, ILMN, MNKD, AAPL
Read
Morning Call For Monday, July 3
Article By: Jim Van Meerten
Monday, July 3, 2017 8:19 AM EDT
Sep E-mini S&Ps (ESU17 +0.33%) this morning are up +0.31% and European stocks are higher by +0.91% on signs of strength in global manufacturing activity.
In this article: MNKD, RATE, GOOGL, BMY, RICE, AVAV
Read
Premarket Biotech Digest – Teva, MannKind, Quidel, Applied DNA Sciences Reported Earnings
Article By: KKD Healthcare Analytics
Friday, May 12, 2017 5:40 AM EDT
Teva Pharmaceutical Industries announced its first quarter results. Applied DNA Sciences reported its second quarter loss at $3.4 million.
In this article: BSX, MNKD, QDEL, STAA, TEVA, XNCR, CRBP, AIMT, APDN, NSPR
Read
Mid Cap Best And Worst Stocks - Wednesday, Feb. 8
Article By: E.B. Capital Markets
Wednesday, February 8, 2017 9:19 AM EDT
The average score for mid cap stocks in our universe is 68.85. Over the past four weeks, the average score is 67.90.
In this article: BITA, CMP, NOK, TER, WEN, AZPN, MNKD, MSCC, SIVBQ, GOGO
Read
Morning Call For December 24, 2015
Article By: Jim Van Meerten
Thursday, December 24, 2015 8:00 AM EDT
March E-mini S&Ps (ESH16 +0.05%) are down -0.05% and European stocks are down -0.15% in thin uninspired holiday trade.
In this article: FCX, H, NSC, PBY, TLP, CALM, MNKD, AGEN, CZR, SPKE
Read

Latest Tweets for $MNKD

No tweets yet!

PARTNER HEADLINES

$MNKD

MannKind Initiated With a Buy, $3 Price Target at BTIG
Craig Newman 5/17/2019 3:13:50 PM

I'd take $3 in a buy out right now. $MNKD

MannKind Corporation: Why The Mealtime Insulin Market Will Expand Drastically
David Patterson 6/30/2017 7:09:05 PM

Good article on #MannKind ($MNKD). I agree that the #insulin market will continue to grow. Before investing in this space, it's important to better understand what insulin is, how it works, and why demand is growing: https://scribeschool.net/how-insulin-works.html

1 to 2 of 2 comments